*Staphylococcus aureus* colonisation is the main risk factor for subsequent infection, and this risk is higher if the staphylococci are methicillin-resistant (MRSA) ([@B12]). Children experience particularly high rates of morbidity and mortality from staphylococcal infections ([@B5].

Clonal Complex 398 (CC398) is among the most important livestock-associated (LA) *S. aureus* genotypes, and contact with animals is a well-described risk factor for its colonisation or infection in humans ([@B15]). However, recent studies have described a non-LA-CC398 lineage in humans with no previous contact with livestock ([@B16], [@B7], [@B15]. This lineage has rapidly spread in humans over a wide-ranging geographical area, in particular in Europe and North America, and has been linked to invasive infection where it has been reported. These *S. aureus* isolates usually carry *spa* type t571 or t1451 ([@B17], [@B16], [@B7], [@B15].

In Brazil, as in all of Latin America, formal, integrated, or systematic *S. aureus* epidemiological surveillance systems are almost universally absent. To date, only three cases of CC398 have been reported in Brazil. The first was an MRSA isolate from a healthy dairy cow (staphylococcal protein A type t011) from a farm in the state of São Paulo ([@B14]), the second was an MSSA isolate that led to fatal pneumonia in a cancer patient in São Paulo (t034) ([@B4]) and the most recent was a case of an MRSA that was isolated from a patient with cystic fibrosis who had previous contact with farm animals ([@B8]). In South America, outside of Brazil, CC398 has also been reported in Colombia, also resulting in the death of the patient ([@B6]), and Peru, where it was isolated from several pigs at a commercial farm ([@B1]).

Here, we report six cases of nasal colonisation by MRSA CC398 among children without any previous exposure to traditional CC398 risk factors (living in or having recently travelled to rural areas, or having recent contact with farm animals or livestock) between August 2011 and March 2016 in the cities of Niterói and Rio de Janeiro, Brazil.

The six CC398 bacterial isolates were identified from nasal swabs of 1852 children sampled in four different settings, including both outpatient and inpatient clinics, and 23 daycare centres. Four CC398 isolates were identified from a sampling of 500 children at two public inpatient clinics, while two were identified among 852 children reporting to paediatric outpatient clinics at two public hospitals. There were no children colonised with CC398 among the 500 sampled at 23 different daycare centres. All children attending the study sites during the period, whose parents agreed to the terms, were included in the study.

A total of 1852 nasal swab samples were collected in the cities of Niterói and Rio de Janeiro between 2011 and 2016 from children in five independent MRSA surveillance studies, in day care centres and public hospitals. The samples were submitted for laboratory testing of catalase and coagulase, plating in mannitol, antibiogram generation and for polymerase chain reaction (PCR) of the *mec*A gene, to identify MRSA samples. All 179 identified MRSAs were genotyped by PCR, multiplex-PCR (Oliveira & de Lencastre 2002), *spa*-Typing (staphylococcal protein A typing) ([@B13] and Multi-locus sequence type (MLST) methods ([@B3]. Six were identified as ST398 by MLST. Five had the t1451 *spa* type and one was t1985. Five carried the SCC*mec* IV and one the SCC*mec* V. All six CC398 strains were non-typeable by PFGE with *Sma*I, corroborating previous reports ([@B7], [@B15]. The species specificity of all isolates was confirmed by a positive PCR reaction for both the *SA442* and *fem*A genes.

Antimicrobial susceptibility was performed with 14 antimicrobial disks (oxacillin, cefoxitin, penicillin, ciprofloxacin, chloramphenicol, clindamycin, erythromycin, nitrofurantoin, gentamicin, rifanpicin, trimethoprim, sulfamethoxazole, tetracycline and vancomycin) according to The Clinical and Laboratory Standards Institute guidelines ([@B2]), and resistant isolates were subjected to PCR for the identification of resistance genes. Four isolates were resistant to erythromycin (4/6, 66.7%), with all six (100%) demonstrating an induced resistance to clindamycin (D-test positivity) that was encoded by the *erm*(C) gene. One isolate was resistant to trimethoprim/sulfamethoxazole (1/6, 16.7%). This was confirmed by PCR of the *dfr*G gene.

PCR was used to confirm the presence of genes encoding staphylococcal enterotoxins (SEs) (*sea*, *seb*, *sec*, *sed*, *see*, *seg*, *seh*, *sei*, *selj*, *selk*, *sell*, *selm*, *seln*, *selo*, *selp*, *selq*, *selr* and *tst1*) and *lukS/lukF*, encoding Panton-Valentine leukocidin (PVL). All isolates carried multiple SE genes ([Table](#t1){ref-type="table"}), and three (50%) were PVL-positive ([@B9], [@B11]).

TABLEGenotype profiles of CC398 methicillin-resistant *Staphylococcus aureus* (MRSA) strains colonising the nares of six children in Rio de Janeiro, Brazil, 2011-2016IsolateLocationDate of CollectionRidom *spa* typeSCC*mec* typeAntimicrobial resistanceResistance genesOther genesAMBU125Outpatient7/3/2012t1451IVPEN, OXA, CFO, ERY^D^*bla*Z, *mec*A, *emr*(C)PVL, *fem*A, *seg*, *sei*, *selk*, *selm*, *seln*, *selo*, *selq, selr*HGVF080Inpatient9/15/2011t1451IVPEN, CFO, ERY^D^*blaZ*, *mec*A, *emr*(C)*fem*A, *seg*, *selk*, *selm*, *seln*, *selo*, *selp, tst1*HGVF396Inpatient7/17/2012t1451IVPEN, CFO*blaZ*, *mec*APVL, *fem*A, *sea*, *seg*, *seh*, *sei*, *selk*, *sell*, *selm*, *seln*, *selo*, *selp*, *selq, selr*HGVF398Inpatient7/19/2012t1451IVPEN, CFO, OXA*blaZ*, *mec*APVL, *fem*A, *seg*, *seh*, *sei*, *selk*, *sell*, *selm*, *seln*, *selo*, *selp*, *selr, tst1*P1036COutpatient4/22013t1985IVPEN, CFO, ERY^D^, TMP, SMX*blaZ*, *mec*A *emr*(C), *dfr*G*fem*A, *seg*, *sei*, *selk*, *selm*, *seln*, *selo*, *selp, selr*DMC49Outpatient19/3/2016t1451VPEN, CFO, OXA, ERY^D^*blaZ*, *mec*A, *emr*(C)*fem*A, *seg, selj, selp*[^2]

All six CC398 carriers resided in the urban centre or suburban periphery of Rio de Janeiro, and none reported any contact with livestock or farm animals.

The isolation of CC398 from individuals without any of the lineage's traditional risk factors suggests the routine transmission of this lineage in several proximate Brazilian urban areas. The isolates exhibited phenotypic and genotypic characteristics consistent with an emergent non-LA-CC398 MSSA strain that is closely related to invasive human infection ([@B17], [@B7]), suggesting that CC398 may have arrived as MSSA and acquired SCC*mec* in a healthcare setting. Importantly, there were no CC398 isolates in a (2006) surveillance study of cattle conducted by our group in the same geographic area (Unpublished data). Our study describes molecular virulence and resistance characteristics of several non-LA-CC398 MRSA. The intrinsic virulence features of CC398 MSSA described elsewhere and the presence of the same virulence features in the MRSA isolates described here (which are also antibiotic resistant), highlight the risk of invasive infection by these emergent strains ([@B17], [@B7]).

Given the history of the rapid spread of non-LA-CC398 in humans ([@B7]), the affinity that these isolates have for the acquisition of the SCC*mec* cassette ([@B15]), and the lack of *S. aureus* epidemiological surveillance in Brazil, these findings suggest that the dissemination of CC398 in the country has been widely underreported. Underscoring this, the isolate was identified among children seeking healthcare for reasons other than the traditional risk factors for colonisation or infection ([@B12]. We must urgently increase the quality of *S. aureus* epidemiological surveillance in Brazil, and elsewhere in Latin America, to avoid infections with other poorly molecularly and epidemiologically described isolates.
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